Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 28, 2020; 26(24): 3472-3483
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3472
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3472
Group and time point | Ascites depth (mm) |
TIPS group | |
Before treatment (n = 37) | 95 (30) |
1 wk after treatment (n = 36) | 35 (35)c |
2 wk after treatment (n = 35) | 0 (13)ac |
1 mo after treatment (n = 35) | 0 (0)ac |
3 mo after treatment (n = 35) | 0 (0)ac |
P value | < 0.001 |
Conservative treatment group | |
Before treatment (n = 17) | 85 (20) |
1 wk after treatment (n = 17) | 71 (34) |
2 wk after treatment (n = 16) | 69.5 (37) |
1 mo after treatment (n = 16) | 56.5 (53) |
3 mo after treatment (n = 12) | 31 (74) |
P value | 0.158 |
- Citation: Zhou CZ, Wang RF, Lv WF, Fu YQ, Cheng DL, Zhu YJ, Hou CL, Ye XJ. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World J Gastroenterol 2020; 26(24): 3472-3483
- URL: https://www.wjgnet.com/1007-9327/full/v26/i24/3472.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i24.3472